newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

FRAMINGHAM, MA / ACCESSWIRE / October 22, 2024 / Xenetic Biosciences, Inc. , a biopharmaceutical company focused on advancing innovative immuno-oncology